Fred Cohen, assistant professor of medicine and neurology at the Icahn School of Medicine at Mount Sinai in New York, told ...

An Asheville specialty pharmaceutical company is working to transform a century-old medical procedure into a treatment for migraine relief that patients can easily perform at home. Olfax Medical has ...

DARIEN, Conn., Dec. 3, 2024 /PRNewswire/ -- Medical device maker CEFALY Technology today launched the CEFALY Pregnancy Registry, a new research registry that will gather information about the safety ...

A "game-changing" new discovery by researchers at King’s College London could revolutionise treatment for asthma and COPD patients. The first breakthrough in treatment in 50 years involves an ...

A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a "game-changer" and lead to the first leap in treatment for 50 years, researchers have said.

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation. It is currently used as a repeat treatment for severe asthma at a low ...

Benralizumab is the first treatment for asthma attacks and chronic obstructive pulmonary disease (COPD) in 50 years. The drug, which is delivered by an injection, helps to treat flare-ups of the ...

Once in a while, we all get a headache. And 70% of the time, it’s caused by stress and tension. Most people will pop a painkiller and hope the pain goes away quickly. But for migraine sufferers ...

A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a “game-changer” and is the first leap in treatment for 50 years, researchers say. Offering ...

Individuals also experienced an enhanced quality of life under the new treatment scheme. Researchers highlighted that steroids, while commonly used, carry significant risks such as heightened ...

A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a “game-changer” and is the first leap in treatment for 50 years, researchers say.